Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews

The recommended antiviral drugs available for the treatment and prevention of influenza are neuraminidase inhibitors (NAIs). The aim of this study was to evaluate age-related clinical manifestations of adverse events (AEs) related to NAIs. FAERS and WebMD data were downloaded. The available NAIs sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Nayoung, Oh, Jung Mi, Kim, In-Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033147/
https://www.ncbi.nlm.nih.gov/pubmed/32080337
http://dx.doi.org/10.1038/s41598-020-60068-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033147/
https://www.ncbi.nlm.nih.gov/pubmed/32080337
http://dx.doi.org/10.1038/s41598-020-60068-5

Ejemplares similares